Potassium Ion

SCHEMBL3861332

O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)(O)OOS(=O)(=O)O.O=S(=O)([O-])OOS(=O)(=O)[O-].O=S(=O)([O-])OOS(=O)(=O)[O-].O=S(=O)([O-])OOS(=O)(=O)[O-].O=S(=O)([O-])OOS(=O)(=O)[O-].O=S(=O)([O-])OOS(=O)(=O)[O-].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+].[K+]

nearest known ligand 0.62

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

AGTR1 DHFR GABBR1 GABBR2 GABRA1 GABRA2 GABRA3 GABRA4 GABRA5 GABRA6 GABRB1 GABRB2 GABRB3 GABRD GABRE GABRG1 GABRG2 GABRG3 GABRP GABRQ GART NR3C2 PBP2X PTGS1 PTGS2 VKORC1 bla blaT-3 blaT-4 blaT-5 blaT-6 dacA dacB dacC folA ftsI mrcA mrcB mrdA pbp1a pbp1b pbp2a pbp2b pbp3 pol thyA

The experimentally established mechanism targets of Potassium Ion. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 6)

	gene	UniProt	supporting neighbours	confidence
▸	CA2	P00918	1/20	0.62

▸	TSHR	P16473	2/20	0.39

▸	MEN1	O00255	1/20	0.39

▸	ALDH1A1	P00352	1/20	0.39

▸	KMT2A	Q03164	1/20	0.39

▸	TDP1	Q9NUW8	1/20	0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
Potassium Ion SCHEMBL27432979	1.00	CA2 (0.62)	CA2TSHRMEN1ALDH1A1KMT2A
Potassium Ion SCHEMBL3863968	1.00	CA2 (0.62)	CA2TSHRMEN1ALDH1A1KMT2A
Potassium Ion SCHEMBL9720346	1.00	CA2 (0.62)	CA2TSHRMEN1ALDH1A1KMT2A
Potassium Ion SCHEMBL338040	1.00	CA2 (0.62)	CA2TSHRMEN1ALDH1A1KMT2A
Potassium Ion SCHEMBL10677211	1.00	CA2 (0.62)	CA2TSHRMEN1ALDH1A1KMT2A
Potassium Ion SCHEMBL9157649	1.00	CA2 (0.62)	CA2TSHRMEN1ALDH1A1KMT2A
Potassium Ion SCHEMBL8097298	1.00	CA2 (0.62)	CA2TSHRMEN1ALDH1A1KMT2A
Potassium Ion SCHEMBL8768422	1.00	CA2 (0.62)	CA2TSHRMEN1ALDH1A1KMT2A
Potassium Ion SCHEMBL7998268	1.00	CA2 (0.62)	CA2TSHRMEN1ALDH1A1KMT2A
Potassium Ion SCHEMBL16861198	1.00	CA2 (0.62)	CA2TSHRMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
EP-1713434-A4	CONDITIONING HAIR LIGHTENER SYSTEM, COMPOSITIONS, METHOD AND KIT THEREFOR	AVLON IND INC (US)	2009-01-07	—	—	EP	disclosed
EP-1713434-A1	CONDITIONING HAIR LIGHTENER SYSTEM, COMPOSITIONS, METHOD AND KIT THEREFOR	AVLON INDUSTRIES INC. (US)	2006-10-25	—	—	EP	disclosed
WO-2005072689-A1	CONDITIONING HAIR LIGHTENER SYSTEM, COMPOSITIONS, METHOD AND KIT THEREFOR	AVLON INDUSTRIES, INC. (US)	2005-08-11	—	—	WO	disclosed